From Multiple Myeloma to Acute Myeloid Leukemia: A Case Report of a 61-year-old Woman after 8 Years of Chemotherapy and Immunotherapy.

Abstract

BACKGROUND:

As the second most prevalent hematologic malignancy, multiple myeloma (MM) affects plasma cells and is characterized by chromosomal abnormalities, particularly involving the immunoglobulin heavy chain switch region. MM represents a biologically and clinically heterogeneous hematological malignancy that serves as a clonal evolution model, exhibiting clonal heterogeneity throughout all stages from monoclonal gammopathy undetermined significance (MGUS) and smoldering multiple myeloma (SMM) to MM. Although significant progress has been made in the treatment of MM, leading to improved patient outcomes, concerns are arising regarding disease relapse due to the presence and selection of pre-existing resistant clones or selective pressure during therapy.

CASE PRESENTATION:

We present a case of multiple myeloma (MM) in a female patient, who underwent an 8-year course of treatment, including chemotherapy, immunomodulators, hematopoietic stem cell transplantation, CD38 monoclonal antibody, and chimeric antigen receptor T-cell (CAR-T), and was recently diagnosed with concurrent progressive MM and acute myeloid leukemia (AML). This patient has witnessed the evolution of MM treatment paradigms.

CONCLUSION:

In this course, disease relapses occurred twice, one of which was manifested by a light chain escape (LCE). Moreover, through the course of the disease in this patient, we review the process of clonal evolution that may be relevant.

• Authors: Xue-Hang Fu, Rong-Yan Guan, Zoufang Huang, Yun Li, Guang Lu, Wei-Wei Mou, Jun Du
• Journal: Recent patents on anti-cancer drug discovery (Recent Pat Anticancer Drug Discov) Vol. 19 Issue 3 Pg. 396-401 ( 2024) ISSN: 2212-3970 [Electronic] United Arab Emirates
• PMID: 38214323 (Publication Type: Review, Case Reports)
• Copyright: Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Topics

• Humans
• Female
• Middle Aged
• Multiple Myeloma (drug therapy)
• Paraproteinemias (pathology)
• Monoclonal Gammopathy of Undetermined Significance (diagnosis, pathology)
• Leukemia, Myeloid, Acute (drug therapy)
• Hematologic Neoplasms
• Immunotherapy